Bafna Pharmaceuticals Share Price Today | Stock Price & Bafna Pharmaceuticals Share Screener

Track the current stock price of Bafna Pharmaceuticals with an interactive chart. Analyse BAFNAPH share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Bafna Pharmaceuticals stock quote in one place.

The quote of ₹193.97 sits between the 52-week low of ₹99.16 and the 52-week high of ₹193.97, and the latest session moved 10.00% from the previous close.

Screen Bafna Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BAFNAPH shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE878I01022.

Classification

Identifiers and Leadership

Screen BAFNAPH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2020, total assets were ₹71, down from ₹120 in 2019.

Latest statistics put total assets at ₹71 and shareholder funds at ₹51, with a leverage ratio of 0.70.

Screen Bafna Pharmaceuticals income statement and profit fundamentals. Analyze BAFNAPH quarterly results. Bafna Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2019-Jun, revenue was ₹7 and net profit was ₹-2, equal to earnings per unit of ₹-0.90, at an operating margin of -42%.

In that period expenses were ₹10, interest cost ₹0 and tax ₹-2. The next period listed, 2019-Sept, shows revenue of ₹12 and net profit of ₹-1.

Screen BAFNAPH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2020-March, operating activities used ₹34, and net cash flow was an inflow of ₹6.

Over the same period, investing activities provided ₹33 and financing activities provided ₹7.

See Bafna Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check Bafna Pharmaceuticals promoter holding and ownership changes for BAFNAPH on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 75.00%, foreign institutions 9.34%, domestic institutions 0.00% and the public 12.13%, spread across 6,928 shareholders.

The shareholder count was 6,928 in 2026-Mar, compared with 7,062 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Bafna Pharmaceuticals. Bafna Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.

See which indices include Bafna Pharmaceuticals stock. Check BAFNAPH index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Bafna Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Bafna Pharmaceuticals stock events that may affect BAFNAPH share price, along with derivatives, futures and options activity and sector gainers.

11 corporate actions are listed, the most recent entry being Annual General Meeting dated September 11, 2026, with a record date of September 11, 2026.

It is followed by Quarterly Result Announcement dated August 11, 2026 and Quarterly Result Announcement dated May 29, 2026.

Screen BAFNAPH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen BAFNAPH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 4, 2026.

The next most recent announcements are dated September 11, 2026 and September 11, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 6 balance sheet periods, 4 income statement periods, 6 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.